Image 1 of 1


BRUSSELS  -  BELGIUM  - 29 JUNE 2011 --  IF  and Bayer HealthCare Pharmaceuticals launch event of the report "Act against Europe's most common birth defects: one year on" at Radisson Blu EU Hotel. -- Yann Le Cam (left), CEO European Organisation for Rare Diseases (EURORDIS) and Lars Joensson (right), Bayer HealthCare Pharmaceuticals. --  PHOTO: Juha ROININEN /  EUP-IMAGES